Findings {#Sec1}
========

Our study has focused on a 27-year-old woman, in first pregnancy at a gestational age of 38 weeks, who has been submitted to fetal echocardiography. During the investigation it has been identified the presence of a vessel with parallel course, rear and left to thoracic aorta (Fig. [2](#Fig2){ref-type="fig"}). The prenatal ultrasonography with color Doppler has showed a hemiazygos accessory vein that, from the diaphragmatic dome, joining with the superior intercostal vein, seemed to drain into the venous trunk brachial-cephalic left (Fig. [3](#Fig3){ref-type="fig"}). We have assumed it was a rare variant of the azygos vein system: the hemiazygos and accessory hemiazygos veins form common channels which drain into the brachiocephalic vein (Fig. [1](#Fig1){ref-type="fig"}) (Blackmon and Franco [@CR1]). The accessory hemiazygos vein, also called the superior hemiazygos vein, drains into the superior left hemithorax. In the majority of cases there is a small connection to the left superior intercostal vein, and rarely, 1--2 % of the time, the accessory hemiazygos vein drains into the brachiocephalic vein (Galwa et al. [@CR4]).Fig. 1Reconstruction of the anatomical variant of azygos vein system identified in this patient: the hemiazygos and accessory hemiazygos veins form common channels which drain into the brachiocephalic veinFig. 2The prenatal ultrasound shows a vessel with parallel course on the left and posteriorly to the thoracic aortaFig. 3The prenatal ultrasound shows the accessory hemiazygos that drain into the left venous trunk brachial-cephalic

We have started a follow-up with prenatal echocardiography. The patient was born by caesarean section at 40 + 4 w.g, weight 3280 g, stature 50 cm, CC 34 cm, Apgar 1′:9, 5′:10. He has had a good adaptation to extrauterine life. Postnatal echocardiography has confirmed the presence of a hemiazygos accessory vein that drains into the left brachial-cephalic trunk (Fig. [4](#Fig4){ref-type="fig"}). The ultrasound examination has showed no other anatomical or functional cardiac abnormalities. Through color---Doppler it has been possible to confirm the absence of hemodynamic changes in accordance with following the vascular variant.Fig. 4The postnatal echocardiography, through color---Doppler, shows the anterograde flow of blood draining in the left brachiocephalic trunk, as reconstructed in anatomical model in Fig. [1](#Fig1){ref-type="fig"}

Conclusions {#Sec2}
===========

This vascular anomaly has never been detected prenatally. The clinical case we have described is the ideal diagnostic procedure to be followed in a patient with vascular malformation. The prenatal recognition of the vascular anatomy has allowed us to monitor the patient since fetal life and to orient the mode of delivery and assistance at birth. The prenatal ultrasound follow-up has been crucial to monitor the heart function of the fetus, as it has excluded conditions of volume overload and pressure overload of the heart chambers, and to see any other cardiac malformations. We have excluded that this variant of the azygos venous system represents an indication to early cesarean section. Finally, the postnatal ultrasound follow-up has confirmed that this anomaly does not cause hemodynamic vascular changes and does not expose the patient to other cardiovascular complications.

In the management of this case report, it has been very important the collaboration between gynecologists and neonatologists who have accompanied the mother and her unborn child with prudence and expertise providing them with the best care.
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